Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Mindfulness with wearables to help prevent high blood pressure problems in pregnancy

Official title: Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy Study: MINDBP

Run by Medical College of Wisconsin · NCT07218237 · Data updated 2026-11-12

This study tests whether adding mindfulness training with wearable biosensors to standard prenatal care can help prevent hypertensive disorders in pregnant people at risk.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment90 (estimated)
SponsorMedical College of Wisconsin
Academic / other
Locations2 sites (Providence, Rhode Island and 1 other locations)
StatusRecruiting
StartedApril 1, 2026
Main results expectedMarch 1, 2028
Study endsOctober 1, 2028
Registry record updatedSeptember 16, 2026
Trial IDNCT07218237 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant individuals ≤16 weeks gestation who are at moderate to high risk for preeclampsia and meet inclusion criteria.

Probably not a fit

Women with multiple gestations, pregestational hypertension, or active mind-body practices may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The MINDBP study will enroll 90 pregnant individuals at risk for hypertensive disorders of pregnancy and randomize them to three groups: mindfulness training with wearable biosensors, mindfulness training alone, or routine prenatal care. Participants in the mindfulness arms will receive eight weekly phone-based sessions with two booster sessions after the intervention, while all participants wear a Garmin Vivoactive 4. Outcomes include feasibility, fidelity, and acceptability, with physiological and psychological measures (blood pressure, heart rate, heart rate variability, perceived stress, and pregnancy-related anxiety) assessed at baseline (≤16 weeks), after the intervention (~24 weeks), and after each booster (~28 and 32 weeks). The study is conducted at two sites: Brown University and Medical College of Wisconsin, led by MCW with collaboration at Brown.

Why it matters

Potential benefit: If successful, the approach could offer a feasible way to reduce risk factors and improve well-being for at‑risk pregnancies.

How similar studies have gone: Previous work suggests mindfulness and wearables can influence stress and autonomic markers, but direct evidence for preventing hypertensive disorders in pregnancy is limited, making this study relatively novel in its combined approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant patients at gestational age \<= 16 weeks
* Live, non-anomalous gestation
* Normotensive at enrollment
* Meet criteria consistent with 'moderate' to 'high' risk for preeclampsia based on ACOG/USPSTF guidelines for low-dose aspirin administration to prevent hypertensive disorders of pregnancy

Exclusion Criteria:

* Multiple gestation
* Chronic (pregestational hypertension)
* Inability of unwillingness to provide informed consent
* Active suicidality or psychosis
* Ongoing mind-body practice (e.g., yoga, meditation, mindfulness \>= once per week)

Where it's running

  • Brown University
    Providence, Rhode Island, United States
    Recruiting
  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting

Study contacts

  • Principal investigator: Anna Palatnik, MD — Medical College of Wisconsin
  • Study coordinator: Anna Palatnik, MD
  • Email: apalatnik@mcw.edu
  • Phone: 14148056627

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.